Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.
about
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityPioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeysPeroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study.Identification and treatment of metabolic complications in pediatric obesity.Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials.Hirsutism: an evidence-based treatment update.Assessing and treating insulin resistance in women with polycystic ovarian syndromeThe Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.Polycystic ovary syndrome: chemical pharmacotherapy.Medical management of metabolic dysfunction in PCOS.Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity.Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndromeInsulin and hyperandrogenism in women with polycystic ovary syndrome.Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system.Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Thiazolinedione treatment in PCOS--an update.Polycystic ovary syndrome: an overview.Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome.Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.
P2860
Q24197673-94CA19BE-09BE-4D08-92F9-E7965489A2ADQ24240654-753E402D-46D8-4540-9835-645FBE2AB129Q27307174-9C82B4DA-E451-4C53-BC36-C8ADB8847C72Q33772312-D223B6A2-A352-4771-B0A1-9B44C337D253Q33893011-5F44E5B5-26AB-480B-970A-9143E8795F4FQ34148029-C314A16E-9754-4464-8D71-F97ADF309207Q34397685-F06C91D4-8BB0-4717-94FE-C0481A24768CQ34422575-1FDA2553-D69D-4D3F-87EC-6ACA72A9E042Q34878055-16516BDB-C0AB-4AAB-9FB4-9E7C770CC153Q35100131-D9FEB10C-14CC-4521-A3E7-9A9366898E88Q35468539-8A406062-CD46-49AC-A71F-F7B9AF083EE2Q35639510-DE2D0BCF-0C24-48C8-968E-197B4B23487CQ36132055-DE2ACE56-F1E8-428B-9468-FC474EC7A1CFQ36274510-213D55E6-610A-48E0-895A-52204A737716Q37022386-A48F9BC2-07F9-4EE3-9E19-894A7CA3C05DQ37355746-F5B3EE65-648B-40A5-A5CA-EE773A5F2CE0Q37361691-E7195656-4F7A-4732-A51B-F997BD59EBC1Q37547069-489D2622-0341-48C9-B489-9577301A9316Q37570577-AD4199EB-05AD-4BF1-95E2-797ACE2682E9Q37763184-B9BBF586-8567-4130-892B-69C1BB1B0CA4Q37886072-B84BA9C5-5422-41A4-A9B8-189E6DCA46F6Q37953819-072A7598-078D-4536-B413-9F3958F8ECFCQ38102596-59ABF3B2-12AB-466B-A356-8987BC0CB0CBQ47402228-49629B38-AB7A-43B8-807A-19F4DF81C54FQ47642633-1B8CAA2A-1223-45C0-9135-8DB407F786D6Q47932338-46FEE00E-3C75-4C22-8A11-27EFB9F4793FQ51390042-4A56C17C-1A50-4CEC-9EE0-F8BE6DBD00F9Q53134066-BD1D8384-EE4D-4CEB-94B8-A5FEF30B6789Q53746829-08ABFF7B-13A8-4D27-B672-4431DCC27F83
P2860
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@en
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@nl
type
label
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@en
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@nl
prefLabel
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@en
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@nl
P2093
P2860
P356
P1476
Metabolic and hormonal changes ...... ebo-controlled clinical trial.
@en
P2093
Paivi Burke
Paul Clopton
R Jeffrey Chang
Robert R Henry
Sunder Mudaliar
Susan Phillips
Theodore P Ciaraldi
Vanita R Aroda
P2860
P304
P356
10.1210/JC.2008-1133
P407
P577
2008-11-04T00:00:00Z